A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1993
12/14/1993	CA1325212C (benzofuran-2-yl) imidazoles having pharmaceutical activity, their salts and relevant production processes
12/14/1993	CA1325192C Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
12/12/1993	CA2160768A1 Process for the preparation of clavulanic acid
12/09/1993	WO1993024660A1 Method for inhibition of viral morphogenesis
12/09/1993	WO1993024650A1 Therapeutic compositions
12/09/1993	WO1993024647A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses
12/09/1993	WO1993024640A2 Methods and compositions for in vivo gene therapy
12/09/1993	WO1993024616A1 Process for attenuated varicella zoster virus vaccine production
12/09/1993	WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor
12/09/1993	WO1993024528A1 Equine herpesvirus glycoproteins
12/09/1993	WO1993024521A1 Bpc peptides, their preparation and use
12/09/1993	WO1993024513A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof
12/09/1993	WO1993024510A1 Phosphotriester-type biologically active compounds
12/09/1993	WO1993024491A1 Indolocarbazole imides and their use
12/09/1993	WO1993024481A1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and related compounds as antibacterial agents
12/09/1993	WO1993024479A1 Novel fluorinated quinolones, process for their preparation and pharmaceutical preparations containing same
12/09/1993	WO1993024461A1 Tetrahydro and perhydro isoquinolin derivatives and therapeutic agents containing them
12/09/1993	WO1993024148A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
12/09/1993	WO1993024145A1 Compositions useful in diagnosis and prophylaxis of lyme disease
12/09/1993	WO1993024143A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis
12/09/1993	WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993	WO1993024138A1 Biologically active peptides having n-terminal substitutions
12/09/1993	WO1993024127A1 Selective cell inactivation in blood
12/09/1993	CA2306952A1 Method for removing dental plaque
12/09/1993	CA2137087A1 Biologically active peptides having n-terminal substitutions
12/09/1993	CA2136449A1 Tetrahydro- and perhydroisoquinoline derivatives and therapeutic compositions containing these
12/09/1993	CA2135800A1 Compositions useful in diagnosis and prophylaxis of lyme disease
12/09/1993	CA2135194A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof
12/09/1993	CA2134773A1 Methods and compositions for in vivo gene therapy
12/09/1993	CA2114132A1 New fluorinated quinolones, process for their preparation and pharmaceutical compositions containing them
12/08/1993	EP0573107A2 Process for attenuated varicella zoster virus vaccine production
12/08/1993	EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993	EP0572644A1 DERIVATIVES OF 9-($g(b)-D-XYLOFURANNOSYL)ADENINE AND OF 1-($g(b)-D-XYLOFURANNOSYL)CYTOSINE, PREPARATION THEREOF AND APPLICATION IN THERAPEUTICS
12/08/1993	EP0572537A1 Cytokine inhibitors
12/08/1993	EP0572454A1 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants
12/08/1993	EP0572433A1 Antigen-presenting capsid with fusion ms2-coat protein
12/08/1993	EP0572418A1 Novel gamma-pyrones, gamma-pyridones and gamma-thiopyrones and their use as medicaments and method for producing them
12/08/1993	EP0259496B1 Derivatives of cervinomycin antibiotics and process for their preparation
12/08/1993	CN1079224A Antibiotic compounds
12/08/1993	CN1023016C Process for preparing diastereomeric 5R, 6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
12/08/1993	CN1022973C Method and apparatus for preparing food foodstuffs
12/07/1993	US5268482 Containing piperidine ring substituted with ether or sulfide groups
12/07/1993	US5268467 Immunomodulatory polysaccharide fractions from Astragalus plants
12/07/1993	US5268462 Oleandomycin oximes
12/07/1993	US5268389 Containing a benzene ring
12/07/1993	US5268376 Containing alkoxy substitution
12/07/1993	CA2095944A1 Azole derivatives and antimycotic and antiaromatase agents containing them
12/07/1993	CA1325077C Beta-lactam derivatives
12/07/1993	CA1324970C Transformed shigella
12/07/1993	CA1324956C Stable lyophilized live herpes virus vaccine
12/02/1993	DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/01/1993	EP0572287A2 Use of cyclic double-stranded oligonucleotides containing the binding site for a transcription factor for inhibiting gene expression
12/01/1993	EP0572259A1 Aminoquinolone derivatives as anti-HIV agents
12/01/1993	EP0572191A1 N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents
12/01/1993	EP0572110A2 Method of reducing or preventing toxicity associated with antiretroviral therapy by stimulation of the intracellular gluthatione level
12/01/1993	EP0571903A1 A method for preparing low free formaldehyde methylol-hydantoins and compositions thereof
12/01/1993	EP0571870A1 Cyclopentane- and -pentene-beta-amino-acids
12/01/1993	EP0571669A1 Benzenedimethanol derivatives suitable for micronisation
12/01/1993	EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993	EP0571549A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN
12/01/1993	EP0571538A1 Structural gene of pneumococcal protein
12/01/1993	EP0571536A1 Reagents and methods for identification of vaccines
12/01/1993	EP0571524A1 Peroxyacid bleach precursor compositions
12/01/1993	EP0571410A1 Herpes simplex virus-1 deletion variants and vaccines thereof
12/01/1993	CN1078889A Improved pulsatile once-a-day-delivery systems for minocycline
11/1993
11/30/1993	US5266600 Also for treatment of AIDS
11/30/1993	US5266576 N-myristoyl transferase inhibitors
11/30/1993	US5266566 Method of treating fungal infections using sterodial ester compounds
11/30/1993	US5266489 Recombinant herpesviruses, in particular for the production of vaccines, process for preparing them, plasmids produced during this process and vaccines obtained
11/30/1993	CA1324756C Butylated hydroxyanisoles for the treatment of retro-viral diseases, as retro-virus infectivity modifying agents and as anti-infective products
11/28/1993	CA2096998A1 Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent
11/27/1993	CA2096395A1 N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents
11/25/1993	WO1993023569A1 Method and reagent for inhibiting viral replication
11/25/1993	WO1993023544A1 Fusion protein from feline leukaemia virus gp70 as vaccine
11/25/1993	WO1993023543A1 Clostridium perfringens vaccines
11/25/1993	WO1993023427A1 Hiv protein epitopes immunologically homologous to hla
11/25/1993	WO1993023423A1 Canine coronavirus s gene and uses therefor
11/25/1993	WO1993023422A1 Compositions and methods for vaccination against coronaviruses
11/25/1993	WO1993023421A1 Universal coronavirus vaccine
11/25/1993	WO1993023407A1 Novel tricyclic thiazolo and thiazino derivatives and anti-viral medicaments containing them
11/25/1993	WO1993023402A1 3-azetidinylthio-carbapeneme derivatives, their preparation and use as antimicrobial agents
11/25/1993	WO1993023401A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993	WO1993023384A1 Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials
11/25/1993	WO1993023379A1 Retroviral protease inhibitors
11/25/1993	WO1993023373A1 N-[N'-(5-AMINO-4-HYDROXY-ACYLOYL)-α-AMINOACYLOYL] SUBSTITUTED HETEROCYCLES AND THEIR USE AS ANTIVIRAL AGENTS
11/25/1993	WO1993023079A1 Method for nonspecific cellular immune stimulation
11/25/1993	WO1993023062A1 Therapeutic conjugates of toxins and drugs
11/25/1993	WO1993023057A1 Method and reagent for inhibiting cancer development
11/25/1993	WO1993023056A1 Preventive or therapeutic agent for infectious diseases containing mizoribine as active ingredient
11/25/1993	WO1993023046A1 Enantiomeric cynemicin analogs, preparation and use thereof
11/25/1993	WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993	WO1993015103A3 Novel steroid intermediates and processes for their preparation
11/25/1993	WO1992019743A3 Hcv genomic sequences for diagnostics and therapeutics
11/25/1993	DE4216942A1 Tetrahydro- und Perhydroisochinolin-Derivate und diese enthaltende therapeutische Mittel Tetrahydro- and perhydroisoquinoline derivatives and therapeutic agents containing them
11/25/1993	CA2136312A1 Retroviral protease inhibitors
11/25/1993	CA2136234A1 Enantiomeric dynemicin analogs, preparation and use thereof
11/25/1993	CA2136196A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993	CA2135784A1 Method for nonspecific cellular immune stimulation
11/25/1993	CA2135646A1 Method and reagent for inhibiting viral replication
11/25/1993	CA2135499A1 Method and reagent for inhibiting cancer development

1 ... 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 ... 1798